Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÈÄÄí¾ß¸¶ ¼±Ãµ¼º ±ÙÀÌ¿µ¾çÁõ ȯÀÚÀÇ ÇÁ·ÎÆ÷ÆúÀ» ÀÌ¿ëÇÑ ÀüÁ¤¸Æ¸¶Ãë ÇÏ Ä¡°úÄ¡·á

DENTAL TREATMENT IN A PATIENT WITH FUKUYAMA TYPE MUSCULAR DYSTROPHY UNDER TOTAL INTRAVENOUS ANESTHESIA USING PROPOFOL

´ëÇѼҾÆÄ¡°úÇÐȸÁö 2013³â 40±Ç 1È£ p.66 ~ 71
Áø´Þ·¡, ½ÅÅÍÀü, ÇöÈ«±Ù, ±è¿µÀç, ±èÁ¤¿í, ÀÌ»óÈÆ, ±èÁ¾Ã¶, Àå±âÅÃ,
¼Ò¼Ó »ó¼¼Á¤º¸
Áø´Þ·¡ ( Jin Dal-Lae ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
½ÅÅÍÀü ( Shin Teo-Jeon ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
ÇöÈ«±Ù ( Hyun Hong-Keun ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
±è¿µÀç ( Kim Young-Jae ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
±èÁ¤¿í ( Kim Jung-Wook ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
ÀÌ»óÈÆ ( Lee Sang-Hoon ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
±èÁ¾Ã¶ ( Kim Chong-Chul ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
Àå±âÅà( Jang Ki-Taeg ) - ¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç

Abstract

±ÙÀÌ¿µ¾çÁõÀº Á¡ÁøÀûÀÎ ±ÙÀ° ¾àÈ­¸¦ Ư¡À¸·Î ÇÏ´Â À¯ÀüÁúȯÀÌ´Ù. ±× Áß ÈÄÄí¾ß¸¶ ¼±Ãµ¼º ±ÙÀÌ¿µ¾çÁõÀº »ó¿°»öü ¿­¼ºÀ¸·Î À¯ÀüµÇ¸ç, ¿µ¾Æ±â ÃʱâºÎÅÍ ½ÃÀ۵Ǿî ÁßÃ߽Űæ°è, ¾È¸é±Ù µî¿¡µµ ÀÌȯµÇ°í ´Ù¹ß¼º °üÀý±¸Ã൵ ³ªÅ¸³­´Ù. ±ÙÀÌ¿µ¾çÁõ ȯÀڴ ȣÈí±â°è³ª ½ÉÀå µîÀÇ ÇÕº´Áõ ¹ß»ý À§ÇèÀÌ ÀÖÀ¸¸ç, ƯÈ÷ ÈíÀÔ¸¶ÃëÁ¦¸¦ ÀÌ¿ëÇÑ Àü½Å¸¶Ãë ½Ã ¾Ç¼º°í¿­Áõ °¡´É¼ºÀÌ ¹®Á¦°¡ µÈ´Ù. º» Áõ·Ê¿¡¼­´Â ÈÄÄí¾ß¸¶ ¼±Ãµ¼º ±ÙÀÌ¿µ¾çÁõÀ» °¡Áø 3¼¼ 9°³¿ù ¿©¾ÆÀÇ ´Ù¹ß¼º ¿ì½ÄÁõÀ» ÀüÁ¤¸Æ¸¶Ãë ÇÏ¿¡ Ä¡·áÇÏ¿´´Ù. Àü½Å¸¶Ãë À¯µµ ¹× À¯Áö¸¦ À§ÇØ ÇÁ·ÎÆ÷ÆúÀ» È¿°úó ³óµµ , ÁøÅë È¿°ú¸¦ À§ÇØ ·¹¹ÌÆ柴ÒÀ» 1.5 ng/mL ¸ñÇ¥³óµµ Á¶ÀýÁÖÀÔÇÏ¿´´Ù. ÀûÀýÇÑ ¸¶Ãë ½Éµµ¿Í ¾ÈÁ¤ÀûÀÎ »ý¡Èĸ¦ À¯ÁöÇϸç ÇÕº´Áõ ¹ß»ý¾øÀÌ, ÈÄÄí¾ß¸¶ ¼±Ãµ¼º ±ÙÀÌ¿µ¾çÁõ ȯ¾ÆÀÇ ÀüÁ¤¸Æ¸¶ÃëÇÏ ´Ù¹ß¼º Ä¡¾Æ¿ì½Ä Ä¡·á°¡ ¼º°øÀûÀ¸·Î ÀÌ·ç¾îÁ® À̸¦ º¸°íÇÏ°íÀÚ ÇÑ´Ù.

Muscular dystrophy is a genetically heterogeneous group of disorders characterized by progressive muscle weakness of variable distribution and severity. Fukuyama type congenital muscular dystrophy (FCMD) is an unusual form of muscular dystrophy with autosomal recessive inheritance and is clinically characterized by an early age of onset, severe central nervous system involvement, facial muscle weakness, and multiple joint contractures. Muscular dystrophy is susceptible to perioperative respiratory, cardiac and other complications. Patients with FCMD have upper airway muscle weakness, therefore general anesthesia is preferred to sedation regarding maintaining the airway when treating these patients. The development of malignant hyperthermia in general anesthesia for patients with muscular dystrophy is a concern. Total intravenous anesthesia should be used instead of inhaled anesthetics because of the risk of malignant hyperthermia. A 3-year-9-month old, 13kg girl with Fukuyama type congenital muscular dystrophy was scheduled for dental treatment under general anesthesia. She had multiple caries and 14 primary teeth needed caries treatment. Prior to general anesthesia, oral premedication with 9 mg midazolam was given. General anesthesia was induced and maintained with target controlled infusion of propofol . The patient with progressive muscular dystrophy was successfully treated under total intravenous anesthesia with a target controlled infusion of propofol. There were no complications related to anesthesia and dental treatment during or after the operation. This case suggests that target controlled infusion of propofol is a safe and appropriate anesthetic technique in FCMD patients for dental treatment.

Å°¿öµå

ÈÄÄí¾ß¸¶ ¼±Ãµ¼º ±ÙÀÌ¿µ¾çÁõ; ÇÁ·ÎÆ÷Æú; ¸ñÇ¥³óµµ Á¶ÀýÁÖÀÔ; ´Ù¹ß¼º ¿ì½ÄÁõ
Fukuyama type congenital muscular dystrophy; Propofol; Target controlled infusion; Multiple caries

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI